420 related articles for article (PubMed ID: 20369832)
1. Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.
Itoh Y; Ishikawa M; Naito M; Hashimoto Y
J Am Chem Soc; 2010 Apr; 132(16):5820-6. PubMed ID: 20369832
[TBL] [Abstract][Full Text] [Related]
2. Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein.
Okuhira K; Ohoka N; Sai K; Nishimaki-Mogami T; Itoh Y; Ishikawa M; Hashimoto Y; Naito M
FEBS Lett; 2011 Apr; 585(8):1147-52. PubMed ID: 21414315
[TBL] [Abstract][Full Text] [Related]
3. Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist.
Itoh Y; Ishikawa M; Kitaguchi R; Okuhira K; Naito M; Hashimoto Y
Bioorg Med Chem Lett; 2012 Jul; 22(13):4453-7. PubMed ID: 22658364
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of direct binding of cIAP1 degradation-promoting bestatin analogs to BIR3 domain: Synthesis and application of fluorescent bestatin ester analogs.
Sato S; Aoyama H; Miyachi H; Naito M; Hashimoto Y
Bioorg Med Chem Lett; 2008 Jun; 18(11):3354-8. PubMed ID: 18448338
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of nuclear receptor-degradation inducers.
Itoh Y; Kitaguchi R; Ishikawa M; Naito M; Hashimoto Y
Bioorg Med Chem; 2011 Nov; 19(22):6768-78. PubMed ID: 22014751
[TBL] [Abstract][Full Text] [Related]
6. Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.
Okuhira K; Shoda T; Omura R; Ohoka N; Hattori T; Shibata N; Demizu Y; Sugihara R; Ichino A; Kawahara H; Itoh Y; Ishikawa M; Hashimoto Y; Kurihara M; Itoh S; Saito H; Naito M
Mol Pharmacol; 2017 Mar; 91(3):159-166. PubMed ID: 27965304
[TBL] [Abstract][Full Text] [Related]
7. Development of target protein-selective degradation inducer for protein knockdown.
Itoh Y; Ishikawa M; Kitaguchi R; Sato S; Naito M; Hashimoto Y
Bioorg Med Chem; 2011 May; 19(10):3229-41. PubMed ID: 21515062
[TBL] [Abstract][Full Text] [Related]
8. Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor α-induced apoptosis.
Kim S; Ohoka N; Okuhira K; Sai K; Nishimaki-Mogami T; Naito M
Cancer Sci; 2010 Nov; 101(11):2425-9. PubMed ID: 20825417
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
10. Effect of cellular senescence and retinoic acid on the expression of cellular retinoic acid binding proteins in skin fibroblasts.
Si SP; Tsou HC; Lee X; Peacocke M
Exp Cell Res; 1995 Jul; 219(1):243-8. PubMed ID: 7628539
[TBL] [Abstract][Full Text] [Related]
11. Localization of the RAR interaction domain of cellular retinoic acid binding protein-II.
Budhu A; Gillilan R; Noy N
J Mol Biol; 2001 Jan; 305(4):939-49. PubMed ID: 11162104
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion.
Vo HP; Crowe DL
Anticancer Res; 1998; 18(1A):217-24. PubMed ID: 9568080
[TBL] [Abstract][Full Text] [Related]
13. Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinonin.
Sato S; Tetsuhashi M; Sekine K; Miyachi H; Naito M; Hashimoto Y; Aoyama H
Bioorg Med Chem; 2008 Apr; 16(8):4685-98. PubMed ID: 18313309
[TBL] [Abstract][Full Text] [Related]
14. Cellular retinoic acid-binding protein(II) presence in rat uterine epithelial cells correlates with their synthesis of retinoic acid.
Bucco RA; Zheng WL; Davis JT; Sierra-Rivera E; Osteen KG; Chaudhary AK; Ong DE
Biochemistry; 1997 Apr; 36(13):4009-14. PubMed ID: 9092831
[TBL] [Abstract][Full Text] [Related]
15. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
16. Distribution of cellular retinoic acid-binding proteins I and II in the chick embryo and their relationship to teratogenesis.
Maden M
Teratology; 1994 Oct; 50(4):294-301. PubMed ID: 7716736
[TBL] [Abstract][Full Text] [Related]
17. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
Widschwendter M; Daxenbichler G; Dapunt O; Marth C
Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
[TBL] [Abstract][Full Text] [Related]
18. Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells.
Melhus H; Gobl A; Ljunghall S
Biochem Biophys Res Commun; 1994 Apr; 200(2):1125-9. PubMed ID: 8179592
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
20. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
